Healthcare stocks are higher with the NYSE Healthcare Sector
Index rising 0.8% and shares of healthcare companies in the S&P
500 are ahead 1.2% as a group.
In company news, Unilife (
) is taking a beating today, with shares falling over 14% and
touching below $3 apiece following a negative report in Forbes
magazine calling the drug-maker a "parable of broken promises."
The article, "How is a $329 million syringe company still
unprofitable after 11 years," appears in Forbes' Sept. 23 issue and
brands the firm as being a "triumph of story over substance."
In other sector news,
(+) SRDX, (+1.5%) Cuts seven employees, or about 6% of its
current workforce as part of company-wide realignment. Drug-eluding
technology firm expects to take a one-time, pre-tax charge of $0.02
per share against it Q4 earnings.
(-) VVUS, (-7.1%) JMP Securities drops stock to Market Perform
from Outperform, citing possible problems stemming from Anthony
Zook stepping down as CEO of the drug-maker just weeks after being
hired due to health problems.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.